In the first blog we introduced HIV/AIDS, in the second we discussed the initial management, and in this third and final blog of the series we will examine the current and future treatments for HIV/AIDS. Evolution of treatments for HIV Treatments for HIV have evolved...
The beginning of treatments for HIV/AIDS In 1964, Jerome Horwitz developed azidothymidine (AZT) as a potential cancer therapy. It was shown to be ineffective and was subsequently shelved. However, in the 1980s it was included by the National Cancer Institute (NCI) in...
Celebrating the 10th Annual Global Campaign for Patient Safety The much-anticipated MedSafetyWeek – now in its tenth year – is here! This year’s theme, “We can all help make medicines safer,” highlights the collective role we play in ensuring medicine...
Conversations with Industry Leaders: Dr Sue Lim By Dr Stephanie-Jayne Jones On 1st April I caught up with Dr Sue Lim in the latest in my series of “Conversations with Leaders in our Industry”. Dr Lim is an experienced former FDA director and licensed physician with...
Conversation with Industry Leaders: Professor Alan Boyd By Dr Stephanie-Jayne Jones Continuing my series of conversations with leaders in our industry, I caught up with Professor Alan Boyd before Easter. Some of you will know him as the former President of the Faculty...
